- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Yale Profs Take a Piece-by-Piece Approach to Healthcare
Taming U.S. healthcare spending is a huge, daunting task that has met with little success. But some Yale professors are proposing to take a bite-sized approach as a way to change that.
Taming U.S. healthcare spending is a huge, daunting task that has met with little success. But some Yale professors are proposing to take a bite-sized approach as a way to change that.
The “1% Steps for Health Care Reform” project launched by Zach Cooper, Ph.D., and Fiona Scott Morton, Ph.D., promises to offer up “a menu of tangible steps that policymakers can take to lower healthcare costs in the U.S.”
To that end, the project’s website currently has 16 policy briefs posted. Each carries an estimate of the percentage by which proposals in the briefs could reduce healthcare spending.
For example, Cooper and Morton estimate that the changes they propose in their policy brief on out-of-network billing by hospital-based physicians could save$60 billion annually, or 5% of commercial healthcare spending. By their calculation, that works out to 1.67% of total U.S. healthcare spending.
GLP-1s Are Flipping the Script, Says Doug Long | 2024 Asembia
May 1st 2024The growth in spending on the glucagon-like peptide 1 (GLP-1) agonists is a “mega tsunami,” said Doug Long, MBA, vice president industry relations for IQVIA. The script that specialty drugs are the main drivers of U.S. drug expenditures may need some revision.
Read More
Study Reveals Patients Benefit More with Female Doctors — More Particularly Female Patients
April 30th 2024Understanding how physician sex contributes to these disparities is crucial as evidence on the impact of physician sex on clinical outcomes remains limited, especially around patient sex.
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
